Purine-metabolising enzymes and apoptosis in cancer

M Camici, M Garcia-Gil, R Pesi, S Allegrini, MG Tozzi - Cancers, 2019 - mdpi.com
The enzymes of both de novo and salvage pathways for purine nucleotide synthesis are
regulated to meet the demand of nucleic acid precursors during proliferation. Among them …

Emerging role of purine metabolizing enzymes in brain function and tumors

M Garcia-Gil, M Camici, S Allegrini, R Pesi… - International journal of …, 2018 - mdpi.com
The growing evidence of the involvement of purine compounds in signaling, of nucleotide
imbalance in tumorigenesis, the discovery of purinosome and its regulation, cast new light …

Ectonucleotidase inhibitors: a patent review (2011-2016)

M Al-Rashida, SU Qazi, N Batool… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Ectonucleotidases are a broad family of metallo-ectoenzymes that are
responsible for hydrolysing a variety of nucleotides to nucleosides, hence orchestrating the …

Comprehensive analysis of prognostic value and immune infiltration of the NT5DC family in hepatocellular carcinoma

R Li, R Liu, S Zheng, W Liu, H Li, D Li - Journal of Oncology, 2022 - Wiley Online Library
Background. Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
in the world, and its incidence is obviously increasing. The NT5DC family has been shown to …

Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation

O Cadassou, MZ Raza, C Machon, L Gudefin… - Cellular Oncology, 2021 - Springer
Purpose Purine metabolism involves various intracellular and extracellular enzymes,
including cN-II and CD73 that dephosphorylate intracellular and extracellular nucleoside …

Identification of noncompetitive inhibitors of cytosolic 5′-nucleotidase II using a fragment-based approach

Z Marton, R Guillon, I Krimm, Preeti… - Journal of medicinal …, 2015 - ACS Publications
We used a combined approach based on fragment-based drug design (FBDD) and in silico
methods to design potential inhibitors of the cytosolic 5′-nucleotidase II (cN-II), which has …

Cytosolic 5′-nucleotidase II silencing in a human lung carcinoma cell line opposes cancer phenotype with a concomitant increase in p53 phosphorylation

R Pesi, E Petrotto, L Colombaioni, S Allegrini… - International Journal of …, 2018 - mdpi.com
Purine homeostasis is maintained by a purine cycle in which the regulated member is a
cytosolic 5′-nucleotidase II (cN-II) hydrolyzing IMP and GMP. Its expression is particularly …

[HTML][HTML] The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells

G Bricard, O Cadassou, LE Cassagnes… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract The cytosolic 5'-nucleotidase cN-II is a highly conserved enzyme implicated in
nucleotide metabolism. Based on recent observations suggesting additional roles not …

The druggability of intracellular nucleotide-degrading enzymes

C Rampazzo, MG Tozzi, C Dumontet… - Cancer chemotherapy …, 2016 - Springer
Nucleotide metabolism is the target of a large number of anticancer drugs including
antimetabolites and specific enzyme inhibitors. We review scientific findings that over the …

Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator

R Pesi, S Allegrini, F Balestri, M Garcia-Gil, F Cividini… - Cells, 2021 - mdpi.com
Cytosolic 5′-nucleotidase II (NT5C2) is a highly regulated enzyme involved in the
maintenance of intracellular purine and the pyrimidine compound pool. It dephosphorylates …